Need for and Access to Health Care and Medicines: Are There Gender Inequities?

Sapienza University of Rome, Italy
PLoS ONE (Impact Factor: 3.23). 03/2013; 8(3):e57228. DOI: 10.1371/journal.pone.0057228
Source: PubMed


Differences between women and men in political and economic empowerment, education, and health risks are well-documented. Similar gender inequities in access to care and medicines have been hypothesized but evidence is lacking.
We analyzed 2002 World Health Survey data for 257,922 adult respondents and 80,932 children less than 5 years old from 53 mostly low and middle-income countries. We constructed indicators of need for, access to, and perceptions of care, and we described the number of countries with equal and statistically different proportions of women and men for each indicator. Using multivariate logistic regression models, we estimated effects of gender on our study outcomes, overall and by household poverty.
Women reported significantly more need for care for three of six chronic conditions surveyed, and they were more likely to have at least one of the conditions (OR 1.41 [95% CI 1.38, 1.44]). Among those with reported need for care, there were no consistent differences in access to care between women and men overall (e.g., treatment for all reported chronic conditions, OR 1.00 [0.96, 1.04]) or by household poverty. Of concern, access to care for chronic conditions was distressingly low among both men and women in many countries, as was access to preventive services among boys and girls less than 5 years old.
These cross-country results do not suggest a systematic disadvantage of women in access to curative care and medicines for treating selected chronic conditions or acute symptoms, or to preventive services among boys and girls.

Download full-text


Available from: Amy Graves, Dec 19, 2013
31 Reads
  • Source
    • "Consistent with this hypothesis, researchers have found that female family members were in an inferior economic position [12] . Nevertheless, the results of an investigation based on data from the World Health Organization for the year 2002 did not identify gender differences in accessibility, targeting diseases of an acute or chronic nature [4] , or prophylactic or therapeutic care. Indeed the same pattern has been observed elsewhere: while women had greater familial responsibilities than men, they were not a barrier to the access or use of healthcare services [13] . "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: Healthcare accessibility is necessary to achieve good health outcomes. However, access to healthcare can be decreased due to distance to healthcare centres, high costs, or waiting lists. The present study explored if there is a gender gap related to healthcare accessibility constraints. Methods: We performed a cross-country transversal study to investigate the existence of gender-related healthcare accessibility constraints using Mann-Whitney U tests. The research was based on self-reported unmet needs for medical examination due to access barriers according to Eurostat. We examined annual observations from 2005 through 2011 from eight European countries: Greece, France, Germany, Ireland, Italy, Portugal, Spain, and the United Kingdom. Conclusions: We found a gender gap related to unmet medical needs due to high costs, with females more likely to have such needs. The difference in mean values related to gender was statistically significant for Greece (5.17% vs. 3.59%; p = .007), France (1.80% vs. 1.23%; p = .007), Ireland (1.53% vs. 1.13%; p = .011), and Italy (4.39% vs. 2.99%; p = .004).
    11/2014; 3(6):163-173. DOI:10.5430/jha.v3n6p163
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To examine gender differences in access to prescribed medicines in 15 lower and middle income countries. Methods: The proportion of consultations with at least one prescription for women in three age groups (<15, 15-59, 60+ years) with acute respiratory infections (ARI), depression and diabetes in routine audits was compared to the expected proportion calculated from WHO Global Burden of Disease estimates. Newer oral hypoglycaemic medication prescribing was also analysed. Differences reported by country, age group, and condition. Findings: 487,841 consultations examined between January 2007 and September 2010 in low (n = 1), lower middle (6), and upper middle income (8) countries. No country favoured one gender exclusively, but gender differences were common. Taking the 15 countries together, only diabetes treatment revealed a significant difference, with women being treated less often than expected (p = 0.02). No consistent differences found across countries grouped by World Bank income category, WHO region or Global Gender Gap Index. Overall, women had equal access to newer oral hypoglycaemics. Conclusion: Gender differences in access to prescribed medicines for three common conditions are common, but favour neither gender consistently. This challenges prevailing hypotheses of systematic disparities in access to care for women. Evidence about gender disparities should influence policy design.
    Health Policy 02/2013; 110(1). DOI:10.1016/j.healthpol.2013.01.016 · 1.91 Impact Factor
  • Source
    Bulletin of the World Health Organisation 09/2013; 91(9):712-714. DOI:10.2471/BLT.12.109785 · 5.09 Impact Factor
Show more